Dabur India Ltd - 500096 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Transcript of Investor Conference Call
Full Transcript of Dabur India's Earnings Call, Q3FY20
Introductory Remarks:
Demand for the FMCG products continued to see a sharp slowdown with further deceleration during the quarter. Despite the difficult environment, Dabur reported a healthy growth of 7% in consolidated revenue. India FMCG business grew by 5.6% both in value and volume terms. International business reported a growth of 12% on constant currency basis.
In India the healthcare portfolio grew by 10.7% driven by tropical marketing campaign, localized sales activation and sustained investments behind our power brands. Health supplements portfolio grew by 12.2% led by robust growth in Chyawanprash. Digestive category recorded a growth of 15.9% driven by strong performance of Hajmola and Pudin Hara. A new variant of Hajmola tablet was launched - Chatpati Hing, which has been received very well in the market place. Honitus, a part of our cough and cold portfolio reported a double digit growth in the quarter.
While OTC and Ethical business witnessed a muted growth in primary terms. they continue to do well with double digit growth in secondary terms. Within home and personal care portfolio, oral care recorded a growth of 8.5% despite sharp slowdown in the oral care category. Dabur Red, our flagship brand continued to perform well with 9.5% growth leading to an increase of 80 basis points in market share. Red Tooth Powder posted a growth of 10.4% driven by renewed marketing inputs. Babool franchise along with the newly launched Babool Ayurvedic saw a turnaround with a growth of 5%.
Our overall market share in the tooth paste category continued to see an uptick with an increase of around 30 basis points in overall oral care category. Hair Oils reported flattish growth on account of further slowdown in the category. Brahmi Amla and Sarson Amla posted a robust double digit growth.
Our market share in Hair Oils increased by around 50 basis points. We continue to pursue a flanker brand strategy with investments behind our power brand Dabur Amla. Shampoo portfolio reported a 5.1% growth and witnessed an uptick of 60 basis points in market share to touch 5.6%. The bottle portfolio post revamp reported a strong double digit growth of 38% resulting in increase in salience of bottles.
Click PDF for full transcript
